The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Health Service Policy
An immunotherapy treatment for triple negative breast cancer has been provisionally rejected for NHS use in England.
A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.
Waiting to hear if you have cancer, or if your cancer has come back, can be an extremely stressful time – especially if the results take weeks to come back.
Diagnosing cancer at its earliest and most treatable stages is vital to help more people survive their cancer. But it requires having enough NHS staff in place.
Artificial intelligence labs, immigration and NHS funding: what do the latest Government announcements mean for cancer?
The new Government have made several announcements about science and the NHS, including a new Artificial Intelligence lab. But what does it mean for cancer?
A targeted drug with potential to slow the progress of ovarian cancer has been rejected for use on the NHS in England.
Combining an immunotherapy with chemotherapy has been recommended as a treatment for some patients with lung cancer on the NHS in England.
Taking a daily aspirin for more than two years could reduce the risk of bowel cancer in people with Lynch syndrome, according to new draft guidance from NICE.
With a new Prime Minister in office, the Government's commitments to supporting the NHS and building on the strength of science in the UK must become reality.
A targeted drug for advanced ovarian cancer will be more widely available for certain patients on the NHS in England.